Topiramate in children and adolescents with Tourette syndrome: A case series

Journal of Pediatric Neurology

Volumn 5, Issue 1, 2007, Pages 15-19

  Nelson, Teresita Y ^a   Bost, Mandy T ^a   Lesser, Philip S ^a  

^a Carolina Neurological Clinic   (United States)

Author keywords

Adolescent medicine; Child psychiatry; Developmental behavioral pediatrics; Movement disorders; Topiramate; Tourette syndrome

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIDEPRESSANT AGENT; BUSPIRONE; CENTRAL STIMULANT AGENT; FEXOFENADINE; MELATONIN; NEUROLEPTIC AGENT; PIMOZIDE; RISPERIDONE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TOPIRAMATE; TRICYCLIC ANTIDEPRESSANT AGENT; ZIPRASIDONE;

ADD ON THERAPY; ADOLESCENT; AGGRESSIVENESS; AGITATION; ARTICLE; BODY MASS; BURNING SENSATION; CASE STUDY; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; COORDINATION DISORDER; DECREASED APPETITE; DISEASE SEVERITY; DIZZINESS; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG WITHDRAWAL; FATIGUE; FEMALE; GILLES DE LA TOURETTE SYNDROME; HEAT RASH; HUMAN; MALE; MEDICAL RECORD REVIEW; MENTAL DEFICIENCY; MONOTHERAPY; MOOD DISORDER; NAUSEA; NERVOUSNESS; SEDATION; SIDE EFFECT; TIC; TREATMENT DURATION;

EID: 33847777218     PISSN: 13042580     EISSN: 18759041     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. J. Jankovic, Tourette's syndrome, N Engl J Med 345 (2001), 1184-1192.
2. H.S. Singer, Current issues in Tourette syndrome, Mov Disord 15 (2000), 1051-1063.
3. H.S. Singer, Neurobiology of Tourette syndrome, Neurol Clin 15 (1997), 357-379.
4. J.W. Mink, Basal ganglia dysfunction in Tourette's syndrome: A new hypothesis, Pediatr Neurol 25 (2001), 190-198.
5. R.P. Shank, J.F. Gardocki, A.J. Streeter and B.E. Maryanoff, An overview of the preclinical aspects of topiramate: Pharmacology, pharmacokinetics, and mechanism of action, Epilepsia 41(Suppl 1) (2000), S3-S9.
6. F.S. Abuzzahab and V.L. Brown, Control of Tourette's syndrome with topiramate, Am J Psychiatry 158 (2001), 968.
7. G.S. Connor, A double-blind placebo-controlled trial of topiramate treatment for essential tremor, Neurology 59 (2002), 132-134.
8. N. Gálvez-Jiménez and M. Hargreave, Topiramate and essential tremor, Ann Neurol 47 (2000), 837-838.
9. Diagnostic and Statistical Manual of Mental Disorders DSM-IV, (4th ed.), Washington DC: American Psychiatric Association, 1994.
10. A.K. Shapiro, E.S. Shapiro, J.G. Young et al., Measurement in tic disorders, in: Gilles de la Tourette Syndrome, (2nd ed), A.K. Shapiro, E.S. Shapiro, J.G. Young and T.E. Feinberg, eds, New York: Raven Press, 1988, pp. 451-480.
11. H.S. Singer, J. Wendlandt, M. Krieger and J. Giuliano, Baclofen treatment in Tourette syndrome: A double-blind, placebo-controlled, crossovertrial, Neurology 56 (2001), 599-604.
12. Y. Awaad, A.M. Michon and S. Minarik, Use of levetiracetam to treat tics in children and adolescents with Tourette syndrome, Mov Disord 20 (2005), 714-718.
13. S.L. McElroy, L.M. Arnold, N.A. Shapira et al., Topiramate in the treatment of binge eating disorder associated with obesity: A randomized, placebo-controlled trial, Am J Psychiatry 160 (2003), 255-261.
14. B.A. Johnson, N. Ait-Daoud, C.L. Bowden et al., Oral topiramate for treatment of alcohol dependence: A randomised controlled trial, Lancet 361 (2003), 1677-1685.
15. N.A. Shapira, M.C. Lessig, T.K. Murphy, D.J. Driscoll and W.K. Goodman, Topiramate attenuates self-injurious behaviour in Prader-Willi Syndrome, Int J Neuropsychopharmacol 5 (2002), 141-145.